Propess


Vaginal delivery system
scheduling status
S4
registration number
33/19/0059
What Propess contains
Each vaginal delivery system consists of a non-biodegradable polymeric drug delivery device containing 10 mg dinoprostone (prostaglandin E2) dispersed throughout its matrix and releases approximately 0,3 mg/hour prostaglandin E2 (PGE2) over a 24 hour period.
other ingredients
Crosslinked macrogol (hydrogel); Polyester yarn.
Therapeutic classification
G02AD02. Pharmacotherapeutic group: uterotonics, prostaglandins.
© 2026 SAHPRA. ALL RIGHTS RESERVED